Literature DB >> 14522458

Specific activation of CMV-primed human T lymphocytes by cytomegalovirus pp65 expressed in fission yeast.

Frank Breinig1, Tanja Heintel, Annette Schumacher, Andreas Meyerhans, Manfred J Schmitt.   

Abstract

Threatening virus infections constantly illustrate the growing need for novel vaccines that specifically induce efficient T cell-mediated immune responses. In this study, we used a human whole blood assay to determine the activation of antigen-specific human T lymphocytes by a viral antigen of human cytomegalovirus (HCMV). The major HCMV tegument protein pp65, recombinantly expressed in fission yeast (Schizosaccharomyces pombe), specifically activated antigen-specific CD4- and CD8-positive memory T cells in blood of HCMV seropositive donors. Moreover, the immune response against recombinant pp65, in particular that of CD8 class I major histocompatibility complex-restricted cytotoxic T cells, was similar to the response against the intact HCMV. Since fission yeast cells per se did not activate a significant number of human T lymphocytes ex vivo, the system described here might represent a novel approach in vaccine development as well as in the identification of vaccine candidates directly from human whole blood.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14522458     DOI: 10.1016/S0928-8244(03)00148-2

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  5 in total

1.  Antigen release kinetics in the phagosome are critical to cross-presentation efficiency.

Authors:  Shanshan W Howland; K Dane Wittrup
Journal:  J Immunol       Date:  2008-02-01       Impact factor: 5.422

2.  Coexpression of human perforin improves yeast-mediated delivery of DNA and mRNA to mammalian antigen-presenting cells.

Authors:  B Walch-Rückheim; R Kiefer; G Geginat; M J Schmitt; F Breinig
Journal:  Gene Ther       Date:  2015-08-20       Impact factor: 5.250

3.  Design of cocktail peptide vaccine against Cytomegalovirus infection.

Authors:  Samira Tabaei; Baratali Mashkani; Arezoo Esmaili; Reza Karimi; Saeid Amel Jamehdar
Journal:  Iran J Basic Med Sci       Date:  2016-04       Impact factor: 2.699

4.  Saccharomyces cerevisiae: a versatile eukaryotic system in virology.

Authors:  Rui P Galao; Nicoletta Scheller; Isabel Alves-Rodrigues; Tanja Breinig; Andreas Meyerhans; Juana Díez
Journal:  Microb Cell Fact       Date:  2007-10-10       Impact factor: 5.328

5.  Exploiting the yeast L-A viral capsid for the in vivo assembly of chimeric VLPs as platform in vaccine development and foreign protein expression.

Authors:  Frank Powilleit; Tanja Breinig; Manfred J Schmitt
Journal:  PLoS One       Date:  2007-05-02       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.